Barcelona snapshots

Prof. Sanjay J. Mathew

Sanjay J. Mathew psychiatrist Controversias Psiquiatry Barcelona
Baylor College of Medicine, USA
Talk Glutamatergic function and new approaches for treatment-resistant depression
Date Friday, April 26th, 2019
Time 15:15 to 16:00
Round Table Treatment-resistance in affective disorders

BIOGRAPHY

Sanjay J. Mathew, M.D. is the Marjorie Bintliff Johnson and Raleigh White Johnson, Jr. Chair for Research in Psychiatry, Professor and Vice Chair for Research in the Menninger Department of Psychiatry & Behavioral Sciences at Baylor College of Medicine, and staff psychiatrist at the Michael E. Debakey VA Medical Center (MEDVAMC) in Houston, Texas. He attended medical school at Baylor College of Medicine and completed his psychiatric residency at Columbia University and the New York State Psychiatric Institute, where he also completed a NIH-funded research fellowship in affective and anxiety disorders. Dr. Mathew began his faculty career at the Mount Sinai School of Medicine, where he co-founded and directed the Mood and Anxiety Disorders Program. In 2010, Dr. Mathew was recruited back to his hometown of Houston to direct Baylor and VA's Mood & Anxiety Disorders Program. His research program focuses on developing novel therapies for patients with serious, treatment-resistant mood and anxiety disorders and PTSD, with a particular focus on rapid-acting glutamate-modulating agents.

Dr. Mathew's research program is currently funded by NIMH, Department of Veterans Affairs, Patient-Centered Outcomes Research Institute (PCORI), and industry in the areas of experimental therapeutics and pathophysiology of treatment-resistant depression, suicide, and PTSD. He has authored or co-authored over 120 manuscripts and book chapters, and serves on the editorial board of several journals. He is an elected member of the American College of Neuropsychopharmacology, was elected to the Board of the American Society of Clinical Psychopharmacology, and was formerly Chair of the Program Committee for the Anxiety and Depression Association of America.

Dr. Mathew is a frequent grant reviewer for NIMH, and previously served a 4-year term on the NIMH Interventions Committee for Adult Disorders. He currently serves on a standing VA Merit Review Committee, and on the Data Safety and Monitoring Board for the VA/Dept of Defense Consortium to Alleviate PTSD.

Dr. Mathew serves on the NAMI Greater Houston Advisory Board and the Board of Depelchin Psychiatric Services, and has served as a Medical Advisor to re: MIND (formerly greater Houston Depression and Bipolar Support Alliance) since 2010. An active clinician, Dr. Mathew has been selected by his peers as a "Best Doctor" every year since 2011.

ABSTRACT

REFERENCES